Cannabis Law Report

DECEMBER 7, 2021

On November 16, 2021, the Drug Enforcement Agency (DEA) issued an advance notice of proposed rulemaking , exploring whether or not to create new federal regulations governing the practice of telepharmacy. The DEA’s notice provides the industry with an opportunity to provide insight and feedback that may help shape the new regulations.

DEA 52

DEA Patients Therapy Access 52

Veriheal

FEBRUARY 1, 2021

The filing is backed by MAPS (Multidisciplinary Association for Psychedelic Studies) and calls on the DEA to answer a four-year-old filing requesting approval of his application to become a federally registered marijuana cultivator. Back in 2016, the DEA said they were starting the process of approving “additional marijuana cultivators.”

DEA 63

DEA Therapy Cultivation Media 63

Cannabis Law Report

FEBRUARY 28, 2020

After a significant outcry by the hemp community, the USDA is backing down from its requirement that all hemp be tested at DEA-registered labs for the 2020 season. However, hemp producers should be aware that the USDA expects to begin enforcing the requirement to use DEA-registered labs for the 2021 growing season.

DEA 59

DEA Hemp CBD Agriculture 59

Canna Law Blog

JUNE 1, 2019

Drug Enforcement Administration (DEA) when it comes to DEA’s handling of petitions to remove marijuana from the list of most dangerous drugs. Schedule I is reserved for drugs with a high potential for abuse, no currently accepted medical uses, and a lack of accepted safety for medical use.

DEA 99

DEA Marijuana History Cannabis 99

Cannabis Law Report

FEBRUARY 16, 2022

A 28-page DEA report — authored in August of 2021, and based on Department of Health and Human Services reviews of these psychedelics from 2012 — states, “These five tryptamines have no known medical use in the United States and are not marketed internationally as approved drug products. Read full report at.

DEA 52

DEA Safety Treatment Law 52

The Blunt Truth

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 98

DEA Data Decriminalization Legalization 98

Veriheal

FEBRUARY 23, 2024

As the Drug Enforcement Administration (DEA) and federal government draw closer to moving cannabis from a Schedule I to a Schedule III substance , more groups have begun to put their weight behind the movement. While there is no date yet on when the formal decision from the DEA will be released, it could be as soon as a few weeks from now.

DEA 99

DEA Chronic Pain Treatment Therapy 99

Cannabis Law Report

SEPTEMBER 9, 2019

The DEA’s announcement signals the “beginning of the end” of federal marijuana prohibition, as the policy change allows federal agencies to evaluate and assess the medical use and abuse potential of marijuana with (limited) political interference. BY EMILY BURNS, GREEN LIGHT LAW GROUP —.

DEA 45

DEA Law Policy Safety 45

Cannabis Law Report

JUNE 12, 2021

MONTEREY, CA – Biopharmaceutical Research Company (BRC), an active Drug Enforcement Administration (DEA) license holder, and CURE Pharmaceutical Holding Corp. BRC is a specialty pharmaceutical company that holds several DEA Registrations and is pioneering the federally legal cannabis space in the USA.

DEA 59

DEA Pharmaceutical Research and Development Compliance 59

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. ”We are pleased with the DEA ‘s cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

DEA 66

DEA Clinical Trials THC Research and Development 66

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Cannabis Law Report

JULY 20, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JULY 18, 2022

Indeed, the DEA reports that it is “aggressively striving to halt the spread of cannabis cultivation in the United States,” including through its Domestic Cannabis Eradication/Suppression Program (DCE/SP), which began funding eradication programs in 1979 and has approximately 126 state and local law enforcement agency participants.

DEA 52

DEA Data Decriminalization Legalization 52

Cannabis Law Report

JANUARY 22, 2020

It also directs the Commission to research “important current issues facing law enforcement and the criminal justice system,” and recommends a variety of subjects for study, such as, but not limited to” There is no direct mention of cannabis but a senior DEA appointment we would suggest is a message in itself. DEA Chief of Operations D.

DEA 69

DEA Law Research and Development Strains 69

Cannabis Law Report

JUNE 28, 2021

Drug Enforcement Agency (“DEA”). While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. While CBP has at least provided some response to the initial request, DEA has completely stonewalled the Initiative to date. Drug Enforcement Administration (DEA).

DEA 97

DEA Blood Pressure Safety Policy 97

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Cannabis Law Report

JUNE 10, 2021

(OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has signed a partnership agreement with Biopharmaceutical Research Company , (BRC), an active Drug Enforcement Administration (DEA) license holder, to produce federally-compliant cannabis-based medical products.

Pharmaceutical 75

Pharmaceutical DEA Research and Development THC 75

The Blunt Truth

AUGUST 27, 2020

The DEA has a new hemp rule. Recreational use would be legal for those 21 or older, with the sales tax revenue going to community colleges, public safety, health and roads. dea hemp rule. He did not address the DEA’s new rule and its effect on the industry’s survival. And traffic lights go green. and finally.

DEA 109

DEA Decriminalization Hemp Legalization 109

Canna Law Blog

SEPTEMBER 6, 2023

Many people in the cannabis industry are convinced that this HHS recommendation to the Drug Enforcement Administration (DEA) means that the DEA will undertake this rescheduling (and fairly quickly, too–which would be a huge departure from its refusal to reschedule back in 2016). Just my two cents; feel free to disagree.

Research and Development 114

Research and Development DEA Marijuana Pharmaceutical 114

TheAnswerPage

DECEMBER 9, 2021

Has the Drug Enforcement Administration (DEA) issued any statements about the legal “loop hole” in the Farm Bill and the production and sale of ?8-THC? The DEA specifically lists ?8-THC 8-THC: legal status, widespread availability and safety concerns, Cannabis and Cannabinoid Research 6:5, 362–365, DOI: 10.1089/can.2021.0097.

DEA 52

DEA Agriculture Safety THC 52

TheAnswerPage

DECEMBER 23, 2021

In other words, the Drug Enforcement Agency (DEA) considers psilocybin to have a high potential for abuse, no currently accepted medical use, and a lack of accepted safety for use under medical supervision. Psilocybin is a Schedule I substance under the Controlled Substances Act. See the Answer.

DEA 59

DEA Safety 59

Cannabis Law Report

AUGUST 27, 2021

ACS Laboratory Will Grant its Safety Seal to Any Product Testing Beyond the Minimum for a Full Panel of Tests. ACS Laboratory’s Tested Safe Certified Safety Seal is a physical symbol that products passed the strictest testing guidelines in the U.S. BOCA RATON, Fla. , Aug. BOCA RATON, Fla. , Aug.

Cannabinoids 98

Cannabinoids Programs Safety Hemp 98

Veriheal

AUGUST 23, 2023

A disputable new social media drug reporting bill believes that social media companies should screen client posts and report any drug-related exercises to the DEA. As they work to enhance public safety, elected officers should live unwavering in their obligation to staunchly defend the proper privacy and freedom of expression online.

Media 52

Media DEA Advocacy Legislation 52

NORML

JANUARY 13, 2020

Strait, Senior Policy Advisor, Diversion Control Division, Drug Enforcement Administration (DEA). The legislative hearing notice states that six bills will be discussed, including HR 3884 , the MORE Act, which recently was approved in the House Judiciary Committee by a bipartisan vote of 24-10 and waived by the House Small Business Committee.

Legislation 188

Legislation Marijuana Policy DEA 188

Project CBD

AUGUST 23, 2023

8 Safety Issues Associated with Synthetic Cannabinoids This new generation of designer drugs is reminiscent of “Spice,” “K2,” and other synthetic cannabinoids that emerged in the illicit drug market in the early 2000s. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 90

DEA Therapy Decriminalization Pharmaceutical 90

Veriheal

DECEMBER 19, 2023

The Drug Enforcement Administration (DEA) is working on amending the Farm Bill in 2024 to create new rules and regulations regarding synthetic weed. Since delta-8 is so unpopular in states with legal cannabis, the data suggests that it is often less appealing to consumers than actual weed.

Legalization 111

Legalization Edibles DEA Access 111

Canna Law Blog

SEPTEMBER 15, 2022

The court reasoned there are “numerous conceivable public health and safety reasons” to justify Congress’ and the DEA’s continued regulation of marijuana. These “reasons” came from a 2016 DEA denial of a petition to reschedule marijuana. A lot has changed since 2016.

DEA 82

DEA Marijuana Safety Legislation 82

Canna Law Blog

AUGUST 25, 2020

The outfit actually began in response to the Drug Enforcement Administration (DEA) scheduling MDMA, more or less, which happened on an “emergency” basis in 1985 (you can view MAPS’ impressive archive and play-by-play on all of that here ). The drug caught DEA’s attention when recreational use proliferated. Just kidding!

DEA 86

DEA Therapy Decriminalization Pharmaceutical 86

Dykema (Cannabis Law Blog)

OCTOBER 6, 2023

On the other hand, with no laws or regulations around the production of the plants and fungi, there is no framework for safety or quality control (i.e., On the one hand, this kind of decrim bill arguably democratized access to psychedelics. consistent and accurate dosing). You can find links to stories about both of these items here and here.

Consumption 58

Consumption DEA Decriminalization Access 58

Cannabis Law Report

JUNE 15, 2021

Drug Enforcement Administration-McAlester Resident Office and DEA Denver. The investigation was initiated by the DEA Denver office’s “Front Range Task Force” after a Chinese money laundering organization was identified that sold black market marijuana “to fund and further their criminal activities,” the sheriff office stated.

DEA 66

DEA Concentrates Safety Marijuana 66

Medicinal Genomics

NOVEMBER 5, 2019

This change shouldn’t affect most hemp farmers who have no interest in cultivating psychoactive plants; however, it does remove a safety net. Another potential headache for farmers is that analytical laboratories must be registered with the DEA in order to perform compliance testing. What does this mean for hemp farmers?

THC 81

THC Hemp DEA Banking 81

Veriheal

AUGUST 19, 2020

The Drug Enforcement Administration (DEA) says that the word refers to opium and its derivatives. However, the DEA is an American agency, so it’s unlikely that the EU has consulted their definition. A definition for narcotic is a little complicated to pin down, though. Cannabis certainly wouldn’t fall under that umbrella.

Food 52

Food CBD DEA Safety 52

Canna Law Blog

OCTOBER 1, 2020

According to the CSA (and subsequent regulations ), Schedule I substances have a high potential for abuse, no currently accepted medical use in treatment in the United States, and a lack of accepted safety for use under medical supervision. Presumably, these requirements provided justification for the DEA to burden these religious exemptions.

History 98

History Law DEA Safety 98

Cannabis Law Report

JULY 13, 2021

The California legislation that would decriminalize some psychedelic substances under state law, Senate Bill 519, was approved in a 5-3 vote by the State Assembly’s Public Safety Committee in a June 29th hearing. This vote marks the bill’s first hearing in the Assembly after passing in a 21-16 vote by the State Senate on June 1.

Decriminalization 105

Decriminalization Legislation DEA Safety 105

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. 2 How much does ketamine therapy cost?

Therapy 78

Therapy Access Blood Pressure Treatment 78